Antimicrobial Resistance (AMR) Publications and Resources

In 2018, Wellcome commissioned the Boston Consulting Group to assess the opportunities and challenges around developing vaccines for humans to tackle AMR.  This report uses the World Health Organisation (WHO) priority pathogen list as a starting point. 

Download the full report: ‘Vaccines to tackle drug resistant infections. An evaluation of R&D opportunities’.  

In 2017, the WHO released an updated version of the priority pathogen list of antibiotic-resistant bacteria that pose the greatest threat to human health. The purpose of this list is to guide research and the discovery and development of new antibiotics. 

Download the report and read the update.   

In 2015, the World Organisation for Animal Health (OIE) assembled an ad hoc group to prioritise diseases and pathogens for which vaccines could significantly reduce antimicrobial use in animals. With the current and projected global production growth for swine, poultry and aquaculture, the ad hoc group identified opportunities for the development of several new vaccines as well as the improvement of existing ones. 

Downloand the full report. 

In 2018, as a follow up, OIE assembled another ad hoc group to prioritise diseases and pathogens for which vaccines could reduce use of antimicrobials in cattle, sheep and goats. 

Download the full report.